Join Re-Femme .

Join Re-Femme .Join Re-Femme .
Join Re-Femme .

Join Re-Femme .

Re-Femme provides a curated wellness registry for women navigating cancer treatment. Discover chemo essentials, mastectomy recovery products, and create your personalized registry to share with friend

Active

About

Re-Femme provides a curated wellness registry for women navigating cancer treatment. Discover chemo essentials, mastectomy recovery products, and create your personalized registry to share with friends and family who want to help.
Frequently asked

What does Join Re-Femme . do?

Re-Femme provides a curated wellness registry for women navigating cancer treatment. Discover chemo essentials, mastectomy recovery products, and create your personalized registry to share with friends and family who want to help.

Is Join Re-Femme . trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Join Re-Femme . is 74 out of 100, based on site security posture and privacy practices.

Scores
Measured, not editorial
Agent Readiness
42/100

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Scan this site yourself
Domain Rating
3/100

Strength of the site’s backlink profile, on the industry-standard 0-100 scale. Licensed third-party data, not our opinion.

Check any domain free
Effective Domain Rating
100/100
Underrated vs Ahrefs DR 3

Our own read on real cross-surface visibility rather than raw backlink authority. A site can carry a high Domain Rating and still be invisible where people actually look, which is what this measures.

Run the eDR check
Data Trust
74/100

Whether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.

Star ratings come from visitors, one per person per profile, and are shown exactly as given: we do not weight, curate or filter them. Reviews are published in full alongside the rating that accompanied them.

Comments

No comments yet. Be the first to share your take.